Supaverm

Target species Sheep and lambs. Indications for use, specifying the target species For the control of fascioliasis (due to Fasciola hepatica) and gastrointestinal nematodes and cestodes in sheep and lambs. The combination is active against lungworm, roundworms, tapeworms (heads and segments) and fluke (mature and immature). For the control of the larval stages of Oestrus ovis (Sheep Nasal Bot fly). For the control of inhibited, immature and adult stages of Haemonchus contortus (Barber Pole worm) including benzimidazole resistant strains. Also effective against benzimidazole susceptible strains of the following: Gastro-intestinal roundworms: Ostertagia spp, Trichostrongylus spp, Nematodirus spp, Cooperia spp, Oesophagostomum spp, Chabertia ovina, Bunostomum spp, Trichurus ovis, Strongyloides papillosus. Lungworm: Dictyocaulus filaria Tapeworm: Moniezia spp. Fluke activity: Stage Percentage kill Adults 97-100 % 6-8 weeks immature 91-95 % 5 weeks immature 91 % 3-4 weeks immature 23-73 % Ticks (Ixodes ricinus) feeding on sheep at the time of treatment are likely to produce fewer viable eggs. Contraindications None. Special warnings for target species Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: ∙ Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. ∙ Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Resistance to benzimidazoles (which includes mebendazole) has been reported in Teladorsagia, Haemonchus, Cooperia and Trichostrongylus species in small ruminants in a number of countries including the EU. Resistance to closantel has been reported in Haemonchus in sheep outside the EU. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics To reduce the risk of anthelmintic resistance, dosing programmes should be discussed with a veterinary surgeon. Special precautions for use i. Special precautions for use in animals None ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Wash hands after administration. Wash splashes from skin and eyes immediately. Take off any contaminated clothing. Wash hands and exposed skin before meals and after work. Adverse reactions (frequency and seriousness) At therapeutic doses, the combination is not toxic and causes no side effects. Use during pregnancy, lactation or lay May be administered to pregnant animals. The product may be used during the lactation period but not where milk is used for human consumption. See Withdrawal Periods. Interaction with other medicinal products and other forms of interaction None known.